Oxford Biomedica plc (OXBDF)

Market Cap	901.17M +123.5%
Revenue (ttm)	227.11M +31.0%
Net Income	-40.55M
EPS	-0.36
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	190
Average Volume	10,251
Open	8.17
Previous Close	8.75
Day's Range	8.17 - 8.17
52-Week Range	3.15 - 12.61
Beta	1.04
RSI	40.42
Earnings Date	Mar 26, 2026

About Oxford Biomedica

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. The company operates in two segments, Platform and Product. The Platform segment engages in bioprocessing and process development activities for third parties. The Product segment is involved in the research and de...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1996
• Employees: 986
• Stock Exchange: OTCMKTS
• Ticker Symbol: OXBDF

Financial Performance

In 2025, Oxford Biomedica's revenue was 168.74 million, an increase of 31.01% compared to the previous year's 128.80 million. Losses were -30.13 million, -30.24% less than in 2024.

Financial numbers in GBP